[1]齐冰,孙蔚.肺间质纤维化并发肺气肿病人血清TGF-β，VEGF和IGF-I作用、意义及与吸烟相关性研究[J].现代检验医学杂志,2015,30(06):109-112.[doi:10.3969/j.issn.1671-7414.2015.06.033]
　QI Bing,SUN Wei.Research on the Significance and Role of the Serum TGF-β，VEGF， IGF-Ⅰand Its Correlation with Smoking of the Patients with Combined Pulmonary Fibrosis and Emphysema[J].Journal of Modern Laboratory Medicine,2015,30(06):109-112.[doi:10.3969/j.issn.1671-7414.2015.06.033]
点击复制

肺间质纤维化并发肺气肿病人血清TGF-β，VEGF和IGF-I作用、意义及与吸烟相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年06期
页码:
109-112
栏目:
检验与临床
出版日期:
2015-12-30

文章信息/Info

Title:
Research on the Significance and Role of the Serum TGF-β，VEGF， IGF-Ⅰand Its Correlation with Smoking of the Patients with Combined Pulmonary Fibrosis and Emphysema
作者:
齐冰; 孙蔚
中国医科大学附属盛京医院胸外科，沈阳110004
Author(s):
QI Bing; SUN Wei
Department of Thoracic Surgery， Shengjing Hospital Affiliated to China Medical University，Shenyang 110004，China
关键词:
肺间质纤维化并发肺气肿; 转化生长因子-β1; 血管内皮生长因子; 胰岛素样生长因子Ⅰ; 吸烟; 血清学检测
分类号:
R563；R392.11
DOI:
10.3969/j.issn.1671-7414.2015.06.033
文献标志码:
A
摘要:
目的观察和分析肺间质纤维化并发肺气肿(CPFE)患者血清转化生长因子-β1(TGF-β1)、血管内皮生长因子(VEGF)、胰岛素样生长因子Ⅰ(IGF-I)的表达水平及与患者吸烟情况的相关性。方法选取40例CPFE患者作为A组，选取40例特发性肺间质纤维化(IPF)患者作为B组，选取40例肺气肿作为C组。对三组患者的病程、吸烟情况及动脉血氧分压(PaO2)、二氧化碳分压(PaCO2)血气指标进行检测和比较；对三组患者的血清TGF-β1，VEGF和IGF-I水平进行检测和比较。结果B组患者的病程和吸烟比例均显著低于A组和C组，C组患者的吸烟年限、平均每日吸烟量和PaCO2均显著高于A组和B组，A组患者的PaO2显著高于B组和C组，以上差异均有统计学意义(q=4.056~7.638，χ2=6.084，15.221，P<0.05)；C组患者的血清TGF-β1，VEGF和IGF-I水平均显著低于A组和B组，差异均有统计学意义(q=3.548~6.392，P<0.05)；A组吸烟患者的血清VEGF水平显著低于不吸烟患者(t=6.138，P<0.05)，A组患者的血清VEGF水平与吸烟年限(r=-0.615)、平均每日吸烟量(r=-0.536)呈负相关关系(P<0.05)，B组患者的血清TGF-β1水平与平均每日吸烟量(r=6.375，P<0.05)呈正相关关系，C组患者的血清VEGF水平与吸烟年限(r=-0.592)、平均每日吸烟量(r=-0.556)呈负相关关系(P<0.05)。结论CPFE患者的肺间质纤维化病变与血清TGF-β1，VEGF和IGF-I水平的上升有关，而血清VEGF水平的降低则与患者的吸烟年限和吸烟量具有相关性，可能参与了肺气肿的发病过程。
Abstract:
ObjectiveTo observe and analyze the expression levels of the serum transforming growth factors-β1 (TGF-β1)，vascular endothelial growth factor (VEGF)，insulin-like growth factor Ⅰ(IGF-Ⅰ) and its correlation with smoking of the patients with combined pulmonary fibrosis and emphysema (CPFE)．Methods40 cases of patients with CPFE were selected as group A，40 cases of patients with idiopathic pulmonary fibrosis (IPF) were selected as group B，and 40 cases of patients with emphysema were selected as group C．The smoking status，the course of disease and the blood gas indexes of arterial partial pressure of oxygen (PaO2)，partial pressure of carbon dioxide (PaCO2) of the patients in the three groups were detected and compared．The serum TGF-β1，VEGF and IGF-I levels of the patients in the three groups were detected and compared．ResultsThe course of disease，the smoking ratio of the patients in group B were significantly lower than those in group A or group C．The smoking duration，the daily average amount of smoking，PaCO2 of the patients in group C were significantly higher than those in group A or group B．PaO2 of the patients in group A was significantly higher than that of group B or group C．The above differences were statistically significant (q=4.056~7.638，χ2=6.084，15.221，P<0.05)．The serum TGF-β1，VEGF and IGF-I levels of the patients in group C were significantly lower than those in group A or group B．The difference was statistically significant (q=3.548~6.392，P<0.05)．The serum VEGF level of the smoking patients in group A was significantly lower than that of no-smoking patients (t=6.138，P<0.05)．The serum VEGF level of patients in group A was negatively correlated with the smoking duration (r=-0.615)，the daily average amount of smoking (r=-0.536，P<0.05)．The serum TGF-β1 level of the patients in group B was correlated positively with the daily average amount of smoking (r=6.375，P<0.05)．The serum VEGF level of of patients in group　C was negatively correlated with the smoking duration (r=-0.592)，the daily average amount of smoking (r=-0.556，P<0.05)．ConclusionThe pulmonary interstitial fibrosis of the patients CPFE was related with the rises of the serum TGF-β1，VEGF and IGF-I levels．The decreased serum VEGF level was correlated with the smoking duration and the smoking amount of the patients，may be involved in the pathogenesis of emphysema．

参考文献/References:

［1］彭敏，施举红，蔡柏蔷．肺纤维化合并肺气肿综合征：呼吸内科临床的“新问题”［J］．中国实用内科杂志，2014，34(8)：744-747． Peng M，Shi JH，Cai BQ．Combined pulmonary fibrosis and emphysema syndrome：the clinical“new problem” in respiratory department of internal medicine［J］．Chinese Journal of Practical Internal Medicine，2014，34(8)：744-747．
[2]张旭，杨朝晖．细胞因子与肺间质纤维化的关系［J］．临床合理用药杂志，2014，7(7B)：174-176． Zhang X，Yang ZH．Relationship between cytokines and pulmonary interstitial fibrosis［J］．China Journal of Clinical Rational Drug Use，2014，7(7B)：174-176．
[3]陆芳，葛虓俊，滑炎卿．肺纤维化合并肺气肿的临床和影像学研究进展［J］．中华临床医师杂志(电子版)，2013，7(14)：188-190． Lu F，Ge XJ，Hua YQ．Progress of the clinical and imaging research on combined pulmonary fibrosis and emphysema［J］．Chinese Journal of Clinicians (Electronic Edition)，2013，7(14)：188-190．
[4]侯玉涛，李娟，薛小花，等．探讨肺间质纤维化合并肺气肿综合征患者的临床特点［J］．中国卫生标准管理，2014，5(24)：145-146． Hou YT，Li J，Xue XH，et al．Discusion on pulmonary interstitial fibrosis with emphysema comprehensive clinical characteristics of syndrome patients［J］．China Health Standard Management，2014，5(24)：145-146．
[5]郭健杏，吕晓红，丁会，等．老年肺间质纤维化合并肺气肿35例临床特点［J］．中国老年学杂志，2013，33(2)：290-291． Guo JX，L XH，Ding H，et al．Clinical features of 35 cases of elderly patients with combined pulmonary interstitial fibrosis with emphysema［J］．Chinese Journal of Gerontology，2013，33(2)：290-291．
[6]陈恒屹，康军，崔社怀，等．特发性肺间质纤维化合并肺气肿的临床特征分析［J］．中华肺部疾病杂志(电子版)，2014，7(1)：7-11． Chen HY，Kang J，Cui SH，et al．Clinical characteristics of idiopathic pulmonary fibrosis combined with emphysema［J］．Chin J Lung Dis (Electronic Edition)，2014，7(1)：7-11．
[7]顾金花，陈玲，周丽娜，等．血清VEGF，SCC-Ag和CYFRA21-1对中晚期肺鳞癌化疗疗效评估的价值［J］．现代检验医学杂志，2014，29(5)：123-126． Gu JH，Chen L，Zhou LN，et al．Value of serum VEGF，SCC-Ag and CYFRA21-1 for predicting eesponse to chemotherapy in advanced lung Squamous cell carcinoma［J］．Journal of Modern Laboratory Medicine，2014，29(5)：123-126．
[8]武贵群，高翔，梅长林．TGF-β/Smads通路与肾脏纤维化研究进展［J］．中国中西医结合肾病杂志，2012，13(5)：459-461． Wu GQ，Gao X，Mei CL．Progress of research on TGF-β/Smads pathway and renal fibrosis［J］．Chinese Journal of Integrated Traditional and Western Nephrology，2012，13(5)：459-461．

相似文献/References:

[1]唐玉蓉a,王际亮a,孙婷婷a,等.儿童特发性血小板减少性紫癜Th亚群细胞因子的测定及意义[J].现代检验医学杂志,2015,30(05):143.[doi:10.3969/j.issn.1671-7414.2015.05.045]
　TANG Yu-ronga,WANG Ji-lianga,SUN Ting-tinga,et al.Determination and Clinical Significance of Th Subsets Cytokines in ITP of Children[J].Journal of Modern Laboratory Medicine,2015,30(06):143.[doi:10.3969/j.issn.1671-7414.2015.05.045]
[2]王小丽,刘瑞东.尿TGF-β1检测在诊断慢性肾炎中的临床应用[J].现代检验医学杂志,2015,30(01):88.[doi:10.3969/j.issn.1671-7414.2015.01.024]
　WANG Xiao-li,LIU Rui-dong.Clinical Application of Urinary Transforming Growth Factor-Beta(TGF-β1)Measurement in Diagnosing Chronic Nephritis[J].Journal of Modern Laboratory Medicine,2015,30(06):88.[doi:10.3969/j.issn.1671-7414.2015.01.024]
[3]常 欣,代志彬,李贵贤,等.IGF-1,TGF-β1水平变化与过敏性紫癜患儿肾损害的关系[J].现代检验医学杂志,2017,32(03):101.[doi:10.3969/j.issn.1671-7414.2017.03.027]
　CHANG Xin,DAI Zhi-bin,LI Gui-xian,et al.Relationship between the Change of IGF 1 and TGF-β1 Level and Renal Damage in Children with Allergic Purpura[J].Journal of Modern Laboratory Medicine,2017,32(06):101.[doi:10.3969/j.issn.1671-7414.2017.03.027]

备注/Memo

备注/Memo:
作者简介：齐冰(1979-)，女，大专，研究方向：胸外科护理，临床用药，E-mail：zhouxihn1973@163.com。
更新日期/Last Update: 1900-01-01